Tech Company Financing Transactions
Verrix Funding Round
Verrix, based in San Clemente, secured $8 million from private investors.
Transaction Overview
Company Name
Announced On
11/28/2018
Transaction Type
Venture Equity
Amount
$8,000,000
Round
Series B
Investors
Proceeds Purpose
The Series B funding will allow the company to finalize development, regulatory submission, and commercialization of its Verrix EVA Biological Indicator (BI) System.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
1330 Calle Avanzado
San Clemente, CA 92673
USA
San Clemente, CA 92673
USA
Phone
Website
Email Address
Overview
Verrix is a San Clemente, Calif.-based medical device company that is using the most advanced technologies to help protect patients from healthcare-associated infections. The foundational sterility assurance technology, originally discovered at NASA's Jet Propulsion Laboratory, integrates cutting-edge optical physics, chemistry spectroscopy, and molecular biology.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Cameron Rouns
Chief Scientific Officer
Adrian Ponce
VP - Finance
Timothy Way
VP - Marketing
Erin Manning
VP - Operations
Brian Caufield
VP - R & D
Kok-Hwee Ng
Browse more venture capital transactions:
Prev: 11/28/2018: ModoPayments venture capital transaction
Next: 11/28/2018: Shogun venture capital transaction
Share this article
News on VC Transactions
Our team works diligently to report on every notable VC transaction. All VC database entries reported here are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs